CHRISTIANSON MARK (Business Development Director) sold 11.5% of their position (30K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market sale worth $22.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2025ACC: 0001709738-25-000010
Officer· Business Development Director
Since Feb 2026
-30K
Net shares
Net seller
$22.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−30K
Price / share
$0.74
Trade value
$22.20K
% of position
11.5%
9/5/2025
261.24K→231.24K
Total
Net shares
−30K
Net value
-$22.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2025 | S · Sale | −30K | $0.74 | $22.20K | 11.5% | 261.24K | 231.24K |
| Total | −30K | -$22.20K | ||||||
Derivative Transactions0
No derivative transactions reported